# Tissue-Repair Peptide FAQ — TB-500, GLOW, KLOW — Zee Peptides

> Frequently asked questions about three Recovery & Tissue Repair research peptides — TB-500, GLOW and KLOW — answered from the peer-reviewed literature, with citations.

Direct, citation-anchored answers to the questions readers most often bring to TB-500 and the blends built from it.

## What is GLOW peptide?

GLOW isn't a single peptide — it's a research-vial blend of three peptides: GHK-Cu (a copper-carrying tripeptide), BPC-157 (a gut-derived pentadecapeptide) and TB-500 (a thymosin beta-4 fragment). It's most often marketed for skin renewal alongside general tissue repair. No controlled study has tested the three-peptide combination itself; every claim about GLOW is built from research on its separate ingredients [1][2][4].

## What does the GLOW peptide do?

Its three ingredients are thought to work on different parts of the repair process at once: GHK-Cu nudges skin cells to build more collagen and matrix, BPC-157 helps switch on new blood-vessel growth toward damaged tissue, and TB-500's fragment is believed to help cells migrate to an injury site. Community reports describe brighter, smoother-looking skin and faster-feeling recovery from minor injuries, but these are anecdotal, not clinical evidence — there is no blend-level study confirming any of it [3][4].

## What does GLOW peptide have in it?

The typical research-label composition is GHK-Cu, BPC-157 and TB-500, most commonly listed around a 50 mg / 10 mg / 10 mg ratio in one vial. Ratios vary by supplier and are not independently standardized or verified.

## What peptides are in the GLOW blend?

Three: GHK-Cu (a copper tripeptide), BPC-157 (a pentadecapeptide derived from a stomach-protective protein) and TB-500 (the Ac-LKKTETQ thymosin beta-4 fragment). Some clinics and suppliers use slightly different ratios, but these three ingredients define the blend.

## What is KLOW peptide?

KLOW is a four-peptide research blend: KPV, GHK-Cu, BPC-157 and TB-500 — essentially GLOW's three ingredients with a fourth, anti-inflammatory peptide (KPV) added. A commonly listed vial recipe is 50 mg GHK-Cu with 10 mg each of BPC-157, TB-500 and KPV. It is not FDA-approved and has no combination-level safety or efficacy data [1].

## What is KLOW peptide used for?

In research communities, KLOW is discussed mainly for recovery from tendon, ligament and joint injuries, general achiness, and — via its shared ingredients with GLOW — some skin and gut-comfort effects. These are anecdotal community reports, not clinical indications; no regulatory body has approved KLOW for any human use.

## Where do you inject KLOW peptide?

This site does not provide injection instructions, sites, or dosing guidance for any compound, including KLOW. KLOW is supplied strictly as a research chemical, not an approved medicine, and nothing here should be read as a recommendation for human administration. Community write-ups describe subcutaneous use, but this site does not endorse or detail that practice.

## How much KLOW peptide per day?

This site does not recommend a dose, schedule or frequency for KLOW or any compound discussed here. No controlled human study has established a dose for the four-peptide combination — figures circulated in research communities are unverified and not derived from clinical trials.

## What is TB-500?

TB-500 is the common name for a synthetic seven-amino-acid fragment (Ac-LKKTETQ) of a larger natural protein, thymosin beta-4, corresponding to the protein's actin-binding region. Most published efficacy research used the full-length protein rather than this smaller fragment, a distinction the research literature is explicit about [12].

## What does TB-500 stand for and what does TB stand for in TB-500?

'TB' refers to thymosin beta — TB-500 is a synthetic fragment derived from thymosin beta-4, a naturally occurring repair protein. The '500' in the name is a supplier-derived catalog designation rather than a chemical or dosing reference; it doesn't correspond to a molecular weight or a standard dose.

## What is TB-500 used for in research?

TB-500, and in the underlying research its parent protein thymosin beta-4, is studied for cell migration, new blood-vessel growth, and wound and tendon repair. A 2026 review of unapproved peptide therapies for musculoskeletal conditions names it among compounds with favorable animal-model outcomes but scarce human safety data [1]. It has no FDA-approved therapeutic use and is sold for laboratory research only.

## Does TB-500 work for muscle tears and recovery from exercise?

Research communities frequently report faster-feeling recovery from tendon, ligament and muscle injuries with TB-500 — this is the single most common reason people describe using it, but it is anecdotal, not a measured clinical outcome. Controlled evidence is thinner and mostly indirect: animal studies of the full-length parent protein show improved tissue repair and reduced scarring in models like stroke and skin wounds [11][12], but no controlled human trial has tested TB-500 specifically for muscle-tear recovery or exercise recovery.

---

Think of us as a friendly translator between dense repair-biology papers and everyday language — never a pharmacy, a clinic, or a substitute for your own doctor's advice.